Jason B. Daly - 03 Mar 2025 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
EVP, Chief Legal Officer
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
03 Mar 2025
Net transactions value
-$568,229
Form type
4
Filing time
05 Mar 2025, 20:21:34 UTC
Previous filing
22 Nov 2024
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +22,645 22,645 03 Mar 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability $60,821 -6,943 -31% $8.76 15,702 03 Mar 2025 Direct F3
transaction AMRX Class A Common Stock Options Exercise +38,226 +243% 53,928 03 Mar 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability $95,169 -10,864 -20% $8.76 43,064 03 Mar 2025 Direct F3
transaction AMRX Class A Common Stock Options Exercise +90,580 +210% 133,644 03 Mar 2025 Direct F4
transaction AMRX Class A Common Stock Tax liability $274,521 -31,338 -23% $8.76 102,306 03 Mar 2025 Direct F5
transaction AMRX Class A Common Stock Options Exercise +35,879 +35% 138,185 04 Mar 2025 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability $137,718 -15,579 -11% $8.84 122,606 04 Mar 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -22,645 -50% $0.000000 22,645 03 Mar 2025 Class A Common Stock 22,645 Direct F2, F6
transaction AMRX Restricted Stock Units Options Exercise $0 -38,226 -33% $0.000000 76,453 03 Mar 2025 Class A Common Stock 38,226 Direct F2, F7
transaction AMRX Performance-Based Restricted Stock Units Options Exercise $0 -90,580 -100% $0.000000 0 03 Mar 2025 Class A Common Stock 90,580 Direct F4
transaction AMRX Performance-Based Restricted Stock Units Award $0 +194,064 $0.000000 194,064 03 Mar 2025 Class A Common Stock 194,064 Direct F8, F9
transaction AMRX Restricted Stock Units Award $0 +97,032 $0.000000 97,032 03 Mar 2025 Class A Common Stock 97,032 Direct F2, F10
transaction AMRX Restricted Stock Units Options Exercise $0 -35,879 -25% $0.000000 107,640 04 Mar 2025 Class A Common Stock 35,879 Direct F2, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
F2 Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A Common Stock.
F3 Represents Shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
F4 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2022, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 100% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2025 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
F5 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
F6 On March 3, 2022, the reporting person was granted 90,580 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F7 On March 3, 2023, the reporting person was granted 152,905 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F8 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F9 Represents a performance-based restricted stock unit grant of 97,032 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2028, the last day of the performance period.
F10 The restricted stock units vest in four equal annual installments beginning on March 3, 2026.
F11 On March 4, 2024, the Reporting Person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.